Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12538449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.

  2001cited by this paper
• p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53

  2001cited by this paper
• p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.

  2001cited by this paper
• Does detection of circulating ONYX-015 genome by polymerase chain reaction indicate vector replication?

  2001cited by this paper
• In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.

  2000cited by this paper
• Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples.

  2000cited by this paper
• Erratum: A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (Clinical Cancer Research (2000) 6 (798-806))

  2000cited by this paper
• Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)

  2000cited by this paper
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

  2000cited by this paper
• A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.

  2000cited by this paper
• Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

  2000influential reference
• Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.

  2000cited by this paper
• Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy.

  1999cited by this paper
• Quantification of ribonucleotide reductase expression in wild-type and hydroxyurea-resistant cell lines employing in situ reverse transcriptase polymerase chain reaction and a computerized image analysis system.

  1999cited by this paper
• Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis*

  1999cited by this paper
• p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection

  1998cited by this paper
• Replication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells

  1998cited by this paper
• Micropreparation of cultured cells for in situ reverse transcription PCR.

  1997cited by this paper
• ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

  1997cited by this paper
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

  1996cited by this paper
• Database of p53 gene somatic mutations in human tumors and cell lines.

  1994cited by this paper
• Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection.

  1987cited by this paper
• Alterations to controls of cellular DNA synthesis by adenovirus infection

  1981cited by this paper
• Replication and interaction of virus DNA and cellular DNA in mouse cells infected by a human adenovirus.

  1979influential reference
• Studies of the Mechanism of Enhancement of Human Adenovirus Infection in Monkey Cells by Simian Virus 40

  1972cited by this paper
• Fundamental techniques in virology.

  1969cited by this paper

• Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer

  2017cites this paper
• Loss of HLA class I expression in prostate cancer and restoration using adenoviral and adeno-associated viral vectors

  2016cites this paper
• Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter

  2015cites this paper
• Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.

  2015cites this paper
• Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice

  2015cites this paper
• Cyclin E induction and oncolytic replication of E1b-deleted adenoviruses.

  2013cites this paper
• Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus

  2011cites this paper
• Nouvelles fonctions de p21Cip1 dans la dynamique cytosquelettique des cellules épithéliales mammaires humaines

  2010cites this paper
• Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis

  2010cites this paper
• Death ligands designed to kill: development and application of targeted cancer therapeutics based on proapoptotic TNF family ligands.

  2009cites this paper
• E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer

  2009cites this paper
• Gallbladder cancer.

  2008cites this paper
• Virus combinations and chemotherapy for the treatment of human cancers.

  2008cites this paper
• International progress in cancer gene therapy

  2008cites this paper
• Environmental risk assessment of replication competent viral vectors in gene therapy trials

  2008cites this paper
• Oncolytic Viruses: A New Weapon to Fight Cancer.

  2008cites this paper
• Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses

  2007cites this paper
• ONCOLYTIC ADENOVIRUSES FOR GYNECOLOGIC CANCER

  2007cites this paper
• Adenovector-Mediated Cancer Gene Therapy

  2007cites this paper
• E1A, E1B Double-Restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR–Deficient Biliary Cancers

  2007cites this paper
• Replication Properties of Human Adenovirus In Vivo and in Cultures of Primary Cells from Different Animal Species

  2006cites this paper
• p53 as a target for anti-cancer drug development.

  2006cites this paper
• A demand for next-generation oncolytic adenoviruses.

  2006cites this paper
• Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling.

  2006cites this paper
• Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus

  2006cites this paper
• Doctorate Program in Molecular Oncology and Endocrinology

  2006cites this paper
• The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma

  2005cites this paper
• Cancer scene investigation: how a cold virus became a tumor killer.

  2005cites this paper
• The dl 1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma To the

  2005cites this paper
• Oncolytic adenoviral therapy in gallbladder carcinoma.

  2005cites this paper
• A differential proteome in tumors suppressed by an adenovirus‐based skin patch vaccine encoding human carcinoembryonic antigen

  2005cites this paper
• Targeted Therapy with Imatinib: An Exception or a Rule?

  2005cites this paper
• The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy

  2004cites this paper
• The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma

  2004cites this paper
• Fluorescently labeled adenovirus with pIX-EGFP for vector detection.

  2004cites this paper
• Transductional and transcriptional targeting of adenovirus for clinical applications.

  2004cites this paper
• Fluorescently Labeled Adenovirus with pIX-EGFP for Vector Detection

  2004cites this paper
• ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells.

  2003cites this paper
• [Conditionally replicative adenoviruses: a second wind for cancer gene therapy].

  2003cites this paper
• Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.

  2003cites this paper